Work needed to boost GPs’ knowledge of cancer drug Better coordination is needed between GPs and hospital specialists to improve the former’s knowledge of breast cancer drug tamoxifen, according to a study* published today in the British Journal of General Practice (BJGP).
The Cancer Research UK funded study found poor knowledge amongst GPs of the drug and its preventive benefits for women.
In the UK, more than 53,000 women are diagnosed with breast cancer each year, and 11,000 die of the disease. Women with a family history of the disease have a higher risk and this accounts for 5–10% of all breast cancer cases, so prevention is important. OnMedica
See also:
The Cancer Research UK funded study found poor knowledge amongst GPs of the drug and its preventive benefits for women.
In the UK, more than 53,000 women are diagnosed with breast cancer each year, and 11,000 die of the disease. Women with a family history of the disease have a higher risk and this accounts for 5–10% of all breast cancer cases, so prevention is important. OnMedica
See also:
No comments:
Post a Comment